Page last updated: 2024-08-26

beta-hydroxyisovalerylshikonin and Carcinoma, Lewis Lung

beta-hydroxyisovalerylshikonin has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itabe, H; Kajimoto, S; Kojima, S; Komi, Y; Masuda, M; Nakajo, S; Nakaya, K; Oettgen, P; Shibuya, M; Shimamura, M; Shimokado, K; Suzuki, Y1

Other Studies

1 other study(ies) available for beta-hydroxyisovalerylshikonin and Carcinoma, Lewis Lung

ArticleYear
Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin.
    Cancer science, 2009, Volume: 100, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Chickens; Chorioallantoic Membrane; Drugs, Chinese Herbal; Electrophoretic Mobility Shift Assay; Female; Immunoenzyme Techniques; Immunoprecipitation; Luciferases; Mice; Mice, Inbred C57BL; Naphthoquinones; Neovascularization, Pathologic; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transfection; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2009